Completed PHASE2 INTERVENTIONAL 3-arm NCT00219401

Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea

Sponsor: Papua New Guinea Institute of Medical Research

Conditions Meningitis Otitis Media Pneumonia

Interventions Pneumococcal 7 valent conjugate vaccine (Prevenar®)

Updated 5 times since 2017 Last updated: Jul 10, 2011 Started: May 31, 2005 Primary completion: May 31, 2009 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00219401, this PHASE2 trial focuses on Meningitis and Otitis Media and remains completed. Sponsored by Papua New Guinea Institute of Medical Research, it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Papua New Guinea Institute of Medical Research
The University of Western Australia

Data source: Papua New Guinea Institute of Medical Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Goroka, Papua New Guinea